Melanosome transfer pathway

The melanosome transfer pathway is a multi-step biological process where melanin-synthesizing melanocytes distribute pigment-filled organelles, called melanosomes, to surrounding keratinocytes (Seiberg, 2001). This process is fundamental for skin, hair, and eye pigmentation and serves as the primary defense against UV-induced DNA damage (Ando et al., 2012). The pathway involves the maturation of melanosomes and their transport to the melanocyte's dendritic tips via the Rab27a-melanophilin-myosin Va tripartite complex (Wu and Hammer, 2014). Once at the periphery, melanosomes are internalized by keratinocytes through mechanisms including phagocytosis, which is significantly regulated by the Protease-activated receptor 2 (PAR-2) (Seiberg et al., 2000). Dysregulation of this pathway leads to various pigmentary disorders, such as melasma, solar lentigines, and post-inflammatory hyperpigmentation. Pharmacological modulation of this pathway is a key strategy in dermatology; for instance, niacinamide (Vitamin B3) is a well-documented inhibitor that reduces melanosome transfer without affecting tyrosinase activity (Hakozaki et al., 2002). Other therapeutic agents include PAR-2 antagonists and soybean-derived inhibitors, which block the signaling required for keratinocyte uptake of pigment. Targeting this pathway allows for effective skin lightening while maintaining the viability of melanocytes, offering a safer alternative to traditional bleaching agents.

Other names

Melanosome transportMelanocyte-keratinocyte pigment transferMelanosome translocationPigment transfer pathway

Inhibition of melanosome transfer from melanocytes to keratinocytes, primarily through the antagonism of Protease-activated receptor 2 (PAR-2) on keratinocytes or the disruption of the Rab27a-melanophilin-myosin Va transport complex (Seiberg et al., 2000; Hakozaki et al., 2002).